CLOSE X

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE927.055 (+0.54 %)
PREV CLOSE ( ) 922.05
OPEN PRICE ( ) 928.75
BID PRICE (QTY) 927.05 (286)
OFFER PRICE (QTY) 927.80 (2)
VOLUME 22714
TODAY'S LOW / HIGH ( )913.05 929.40
52 WK LOW / HIGH ( )660.05 1490
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad
Listing : BSE, NSE
NEWS
29Nov NATCO Pharma informs about credit rat
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
21Nov USFDA concludes inspection at Natco Ph
The U.S. Food and Drug Administration (USFDA) has concluded inspection a..
14Nov Demerger
Inter alia, approved:- 1. Declared second interim dividend of Rs.1.50..
31Oct NATCO Pharma informs about press release
NATCO Pharma has informed that it enclosed the Press Release under Regul..
31Oct Natco Pharma launches Everolimus table
Natco Pharma has launched Everolimus tablets 1mg, a generic version of Z..
Financials
Rs. in Millions
QTR Sep 25 ANNUAL 25
Net Profit500918504
Gross Profit 5860 22260
Operating Profit 645824656
Net Sales 1264340945
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Fredun Pharma (BSE)
 1809.95 (3.82%)
M.Cap ( in Cr)849.90
Abbott India (BSE)
 27881.65 (0.21%)
M.Cap ( in Cr)59073.17
Astrazeneca Pharma I (BSE)
 9056.95 (0.50%)
M.Cap ( in Cr)22642.38
Divi's Lab (BSE)
 6367.00 (0.49%)
M.Cap ( in Cr)168798.20
Lupin (BSE)
 2117.30 (1.32%)
M.Cap ( in Cr)96747.70
Shareholding Pattern
PROMOTERS 49.48%
NON-INSTITUTION 30.56%
FI/BANKS/INSURANCE 3.31%
MUTUAL FUNDS/UTI 2.2%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data September 2025 Broking Complaints Data September 2025 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.